Koers Cantabio Pharmaceuticals Inc. Other OTC
Aandelen
CTBO
US13808X2036
Biotechnologie & Medisch Onderzoek
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 2,36 mln. 2,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -1 mln. -926K | Nettowinst (verlies) 2018 | -2 mln. -1,85 mln. | EV/omzet 2017 | - |
Nettoschuld 2017 | 337K 312K | Nettoschuld 2018 | 1,1 mln. 1,01 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-
| Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 29,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06-02-12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22-05-15 |
Max Zhu
BRD | Director/Board Member | 42 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22-05-15 |
Gergely Tóth
FOU | Founder | 51 | 06-02-12 |
Max Zhu
BRD | Director/Board Member | 42 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |